Cargando…

Use of WalkAway MicroScan system colistin well when determining the susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii recent clinical isolates

Detalles Bibliográficos
Autores principales:	Borrego-Jiménez, Jaime, Soria-Segarra, Claudia, Moldovan, Teodora Diana, Navarro-Marí, José María, Gutiérrez-Fernández, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987618/ https://www.ncbi.nlm.nih.gov/pubmed/31895527 http://dx.doi.org/10.37201/req/076.2019

Ejemplares similares

Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway
por: Kulah, Canan, et al.
Publicado: (2009)

Performance Evaluation of BD Phoenix and MicroScan WalkAway Plus for Determination of Fosfomycin Susceptibility in Enterobacterales
por: Bondi, Alessandro, et al.
Publicado: (2023)

Comparative Evaluation of CHROMagar COL-APSE, MicroScan Walkaway, ComASP Colistin, and Colistin MAC Test in Detecting Colistin-resistant Gram-Negative Bacteria
por: Osei Sekyere, John, et al.
Publicado: (2020)

Colistin Susceptibility Testing Using the MicroScan® Colistin Well
por: Lutgring, Joseph, et al.
Publicado: (2017)

P1726 Direct identification and susceptibility testing of staphylococci from positive BacTec blood cultures with WalkAway system
por: Garduño, E., et al.
Publicado: (2007)

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017)

Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations
por: Ramadan, Raghdaa A, et al.
Publicado: (2018)

In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
por: Malekzadegan, Yalda, et al.
Publicado: (2019)

Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates
por: Kon, Hadas, et al.
Publicado: (2021)

Clinical efficacy and safety of colistin treatment in patients with pulmonary infection caused by Pseudomonas aeruginosa or Acinetobacter baumannii: a meta-analysis
por: Zhang, Huagen, et al.
Publicado: (2015)

When Combined with Colistin, an Otherwise Ineffective Rifampicin–Linezolid Combination Becomes Active in Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii
por: Armengol, Eva, et al.
Publicado: (2020)

Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections
por: Balkhair, A., et al.
Publicado: (2023)

Plasmid-Mediated Fluoroquinolone Resistance in Pseudomonas aeruginosa and Acinetobacter baumannii
por: Venkataramana, Geetha P., et al.
Publicado: (2022)

Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii-calcoaceticus Complex
por: Garcia, Rebeca Carvalho Lacerda, et al.
Publicado: (2023)

Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: A cross sectional analytical study
por: Gunalan, Anitha, et al.
Publicado: (2021)

Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii
por: Choi, Hee Kyoung, et al.
Publicado: (2014)

Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection
por: Chen, Zhijin, et al.
Publicado: (2015)

Curcumin alleviates persistence of Acinetobacter baumannii against colistin
por: Kaur, Amanjot, et al.
Publicado: (2018)

Two types of colistin heteroresistance in Acinetobacter baumannii isolates
por: Hong, Yoon-Kyoung, et al.
Publicado: (2020)

New Mutations Involved in Colistin Resistance in Acinetobacter baumannii
por: Sun, Bingbing, et al.
Publicado: (2020)

Colistin Treatment Affects Lipid Composition of Acinetobacter baumannii
por: Tao, Ye, et al.
Publicado: (2021)

Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
por: Novović, Katarina, et al.
Publicado: (2023)

PYED-1 Overcomes Colistin Resistance in Acinetobacter baumannii
por: Stabile, Maria, et al.
Publicado: (2023)

Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
por: Dahdouh, E., et al.
Publicado: (2014)

Inhibitory Effect of Zinc Sulfate on Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii
por: Ramdas, Ishaan, et al.
Publicado: (2020)

In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii
por: Percin, Duygu, et al.
Publicado: (2014)

Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran
por: Vakili, Bahareh, et al.
Publicado: (2014)

Post Neurosurgical Meningitis due to Colistin Heteroresistant Acinetobacter baumannii
por: Moosavian, Mojtaba, et al.
Publicado: (2014)

The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii
por: Mu, Xinli, et al.
Publicado: (2016)

Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii
por: Da Silva, Gabriela Jorge, et al.
Publicado: (2017)

Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii
por: Boinett, Christine J., et al.
Publicado: (2019)

The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii
por: Seleim, Shaimaa Mohamed, et al.
Publicado: (2022)

Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii
por: Kabic, Jovana, et al.
Publicado: (2022)

Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa
por: Cai, Bin, et al.
Publicado: (2017)

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Ayerbe-Algaba, Rafael, et al.
Publicado: (2018)

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea
por: Kim, Chung-Jong, et al.
Publicado: (2022)

Rifampicin and colistin association in the treatment of severe multiresistant Acinetobacter baumannii infections
por: Charra, B, et al.
Publicado: (2008)

The induction and identification of novel Colistin resistance mutations in Acinetobacter baumannii and their implications
por: Thi Khanh Nhu, Nguyen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_32s3om1dup6502o2j13veadiv6